After a long and controversial process, the US Food and Drug Administration (FDA) has approved the first-ever drug aimed at boosting female libido. "Today's approval provides women distressed by their ...

The MarketWatch News Department was not involved in the creation of this content. Recognition follows Addyi's newly expanded FDA approval to treat both premenopausal and postmenopausal women under age ...

Since the U.S. Food and Drug Administration approved flibanserin, a.k.a. “Addyi,” last week (after two previous rejections of the drug), a firestorm of controversy has followed. How effective is the ...

I’m a 37-year-old married female with two small children, a full-time job, and not enough hours in the day. Putting my career as a journalist aside, you’re darn straight I have a lot of questions ...

WASHINGTON -- Drinking alcohol with the female libido booster flibanserin (Addyi) appears somewhat less dangerous than initially thought and the FDA has ordered a label change to reflect the new data ...

Referred to as “female Viagra” or “pink Viagra,” Sprout Pharmaceuticals’ flibanserin (aka Addyi) will treat women who suffer from hypoactive sexual desire disorder. (Photo: iStock) There are currently ...

Update 4:14 pm, Thurs, June 4: The advisory committee voted 0-18-6 in favor of approval of flibanserin for the following question: VOTE: Is the overall benefit/risk profile of flibanserin acceptable ...

Sprout joins the ranks of biotech's biggest names following record-setting growth, expanding prescriber adoption, and increasing payer coverage RALEIGH, N.C., April 29, 2026 /PRNewswire/ -- TIME has ...

RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the ...

About Addyi® (flibanserin) Addyi is the first FDA-approved prescription medication for the treatment of hypoactive sexual desire disorder (HSDD), now including all women under 65. It is a non-hormonal ...